Billionaire investor Bill Ackman said Monday he donated his entire stake in Coupang - worth more than $1 billion - to charity following the South Korean e-commerce company’s...
Keep Reading →
March 15 - Hedge Funds, Insider Trading
Of all the billionaires, hedge fund managers and chief executives who have showered politicians in New York with money in the last five years, no one has given more often than...
Keep Reading →
August 26 - Hedge Funds, Insider Trading
In contrast to yesterday's action, the major indexes are all green today, with crude futures leading the way, up by 5%.
Keep Reading →
April 8 - Market Movers, News
This week's roller coaster is coming to and end with a bang, as U.S. stocks are deep in the red territory and the Dow is down by triple digits.
Keep Reading →
December 18 - Market Movers, News, Tech
Seeing as all three indexes have surged more than 1% in morning trading as the Federal Reserve promises interest rates will still be low for a while, shares of Inland Real Estate...
Keep Reading →
December 15 - News
Cheyne Capital is one of the few non-U.S firms that we track in our database.
Keep Reading →
October 21 - Hedge Fund Analysis, Hedge Funds, News
Stocks in the biotechnology industry have been very active as of late, with companies' shares registering significant gains.
Keep Reading →
March 31 - Hedge Funds, News
According to a Schedule 13D form filed yesterday with the Securities and Exchange Commission, Samuel Islay's Orbimed Advisors has slashed its stake in Intercept Pharmaceuticals...
Keep Reading →
March 26 - Hedge Funds, News
Steve Cohen’s Point72 Asset Management disclosed today a new position in Applied Genetic Technologies Corp (NASDAQ:AGTC). The funds affiliated with Mr.
Keep Reading →
October 7 - Hedge Funds, News
Orbimed Advisors, led by Samuel Isaly, recently published its 13F filing with the U.S. Securities and Exchange Commission.
Keep Reading →
August 28 - Hedge Funds, News
Orbimed Advisors, led by Samuel Isaly, has disclosed cutting its position in Intercept Pharmaceuticals Inc. (NASDAQ:ICPT).
Keep Reading →
August 28 - Hedge Funds, News
Intercept Pharmaceuticals Inc.
Keep Reading →
August 12 - News
After being a dominant player in the hepatitis C market with its drug Sovaldi, Gilead Sciences, Inc.
Keep Reading →
July 18 - News
Small-cap picks from individual funds might provide investors with attractive investment options.
Keep Reading →
June 26 - Hedge Funds, News
Orbimed Advisors is limiting exposure to Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after selling approximately 81,305 shares in one transaction at $320 a piece, according...
Keep Reading →
April 14 - Hedge Funds, News
In another set of filing with the Securities and Exchange Commission, Steven Cohen and his fund, SAC Capital Advisors, have revealed a number of changes to their equity portfolio...
Keep Reading →
April 4 - Hedge Funds, News
Jacob Gottlieb's Visium Asset Management has increased its stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), according to an amended filing with the SEC. Gottlieb's fund...
Keep Reading →
January 10 - Hedge Funds, News
Steve Cohen's SAC Capital has just revealed a 5.3% stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), a new filing with the SEC indicates.
Keep Reading →
November 8 - Hedge Funds, News
Orbimed Advisors, Intercept Pharmaceuticals: Samuel Isaly and his hedge fund, Orbimed Advisors, is focused on healthcare stocks.
Keep Reading →
October 24 - Hedge Funds, News
Orbimed Advisors, Intercept Pharmaceuticals: In a recent SEC filing, Samuel Isaly and his hedge fund, Orbimed Advisors, reported decreasing their holding in Intercept Pharmaceuticals...
Keep Reading →
October 18 - Hedge Funds, News
To the average investor, there are many methods market participants can use to analyze publicly traded companies.
Keep Reading →
September 17 - News
To the average investor, there are tons of methods market participants can use to track publicly traded companies.
Keep Reading →
September 13 - News
In the financial world, there are dozens of indicators investors can use to track publicly traded companies. Two of the best are hedge fund and insider trading movement.
Keep Reading →
September 4 - News
At the moment, there are tons of indicators shareholders can use to analyze publicly traded companies.
Keep Reading →
September 3 - News
In the eyes of many investors, hedge funds are seen as useless, outdated investment tools of a forgotten age.
Keep Reading →
August 30 - News
To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies.
Keep Reading →
August 26 - News
While the market jittered this week over what the Federal Reserve will do next, some stocks didn't flinch.
Keep Reading →
June 24 - News
At the moment, there are plenty of metrics shareholders can use to watch Mr. Market. A pair of the best are hedge fund and insider trading activity.
Keep Reading →
June 17 - News
Is Pacira Pharmaceuticals Inc (NASDAQ:PCRX) a superb investment right now? Hedge funds are in an optimistic mood.
Keep Reading →
June 12 - News
According to most shareholders, hedge funds are seen as unimportant, outdated investment vehicles of years past.
Keep Reading →
June 4 - News
Keryx Biopharmaceuticals (NASDAQ:KERX) was in 6 hedge funds' portfolio at the end of December.
Keep Reading →
April 18 - News
